Divi's Laboratories Share Price

• Overview
• News
• Analysis
• Recos
• Financials
• Forecast
• Technicals
• Peers
• Shareholdings
• MF
• F&O
• Corp Actions
• About
• More
  • MF
  • F&O
  • Corp Actions
  • About
• EnglishEnglishहिन्दीગુજરાતીमराठीবাংলাಕನ್ನಡதமிழ்తెలుగు
  Rank 199 - ET 5002022 ranking

Divis Labs News & Analysis

Divis Labs Share Recommendations

Peer Comparison

Divis Labs Shareholding Pattern

MF Ownership

• SBI Equity Hybrid Direct-G

  Hybrid: Aggressive Hybrid

  3

  • 2,286.78

    Amount Invested (in Cr.)

  • 3.82%

    % of AUM

  • 3.60

    % Change (MoM basis)

• SBI Focused Equity Direct-G

  Equity: Flexi Cap

  3

  • 1,471.02

    Amount Invested (in Cr.)

  • 4.99%

    % of AUM

  • 0.00

    % Change (MoM basis)

• Axis Long Term Equity Direct-G

  Equity: ELSS

  1

  • 1,371.19

    Amount Invested (in Cr.)

  • 4.37%

    % of AUM

  • -8.65

    % Change (MoM basis)

Divis Labs F&O Quote

Corporate Actions

About Divis Labs

Divi's Laboratories Ltd., incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 99,952.90 Crore) operating in Pharmaceuticals sector. Divi's Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals, Scrap, Export Incentives and Contract Fees for the year ending 31-Mar-2022.For the quarter ended 30-06-2023, the company has reported a Consolidated Total Income of Rs 1,859.00 Crore, down 7.83 % from last quarter Total Income of Rs 2,016.92 Crore and down 20.65 % from last year same quarter Total Income of Rs 2,342.91 Crore. Company has reported net profit after tax of Rs 356.00 Crore in latest quarter.The company’s top management includes Dr.Ramesh B V Nimmagadda, Dr.Murali K Divi, Dr.Kiran S Divi, Mr.Madhusudana Rao Divi, Ms.Nilima Prasad Divi, Mr.N V Ramana, Dr.G Suresh Kumar, Mr.K V Chowdary, Mr.K V K Seshavataram, Mr.R Ranga Rao, Dr.S Ganapaty, Prof.Sunaina Singh, Mr.L Kishore Babu, Mr.M Satish Choudhury. Company has Price Waterhouse Chartered Accountants LLP as its auditors. As on 30-06-2023, the company has a total of 26.55 Crore shares outstanding. Show More

Industry

Pharma - Indian

Key Indices Listed on

Nifty 50, Nifty 100, Nifty 200, + 30 more

Address

Divi Towers,1-72/23(P)/DIVIS/303,Cyber Hills, Gachibowli,Hyderabad, Telangana - 500032

Contact

mail@divislabs.com

http://www.divislabs.com

More Details

• Chairman's Speech
• Company History
• Directors Report
• Background information
• Company Management
• Listing Information
• Finished Products

Brands

Divis Labs

FAQs about Divis Labs share

• 1. What's Divis Labs share price today and what are Divis Labs share returns ?
  Divis Labs share price was Rs 3,765.15 as on 29 Sep, 2023, 03:57 PM IST. Divis Labs share price was up by 2.73% based on previous share price of Rs 3,665. Divis Labs share price trend:

  • Last 1 Month: Divis Labs share price moved up by 2.95%
  • Last 3 Months: Divis Labs share price moved up by 4.54%
  • Last 12 Months: Divis Labs share price moved up 1.94%
  • Last 3 Years: Divis Labs Share price moved up by 22.97%
• 2. What is the market cap of Divis Labs?
  Divis Labs share has a market capitalization of Rs 99,952.90 Cr. Within Pharmaceuticals sector, it's market cap rank is 2.
• 3. Should I buy, sell or hold Divis Labs?
  As per Refinitiv (erstwhile Thomson Reuters), overall mean recommendation by 19 analysts for Divis Labs stock is to Hold. Recommendation breakup is as follows

  • 3 analysts are recommending Strong Buy
  • 1 analyst is recommending to Buy
  • 3 analysts are recommending to Hold
  • 9 analysts are recommending to Sell
  • 3 analysts are recommending Strong Sell
• 4. Who are peers to compare Divis Labs share price?
  Within Pharmaceuticals sector Divis Labs, Cipla Ltd., Dr. Reddy's Laboratories Ltd., Mankind Pharma Ltd., Torrent Pharmaceuticals Ltd., Zydus Lifesciences Ltd., Lupin Ltd., Aurobindo Pharma Ltd., Alkem Laboratories Ltd., Biocon Ltd. and Syngene International Ltd. are usually compared together by investors for analysis.
• 5. Who's the owner of Divis Labs?
  Following are the key changes to Divis Labs shareholding:

  • Promoter holding have gone down from 51.94 (30 Sep 2022) to 51.93 (30 Jun 2023)
  • Domestic Institutional Investors holding has gone up from 20.64 (30 Sep 2022) to 21.03 (30 Jun 2023)
  • Foreign Institutional Investors holding have gone down from 15.4 (30 Sep 2022) to 14.69 (30 Jun 2023)
  • Other investor holding has gone up from 12.02 (30 Sep 2022) to 12.35 (30 Jun 2023)
• 6. What is 52 week high/low of Divis Labs share price?
  Divis Labs share price saw a 52 week high of Rs 3,934.70 and 52 week low of Rs 2,730.00.
• 7. How can I quickly analyze Divis Labs stock?
  Divis Labs share can be quickly analyzed on following metrics:

  • Stock's PE is 67.66
  • Price to Book Ratio of 7.93
  • Dividend Yield of 0.80
  • EPS (trailing 12 month) of Divis Labs share is 55.65